The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Programmable Removal of Bacterial Strains by Use of Genome-Targeting CRISPR-Cas Systems
Open accessAbstract
CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems in bacteria and archaea employ CRISPR RNAs to specifically recognize the complementary DNA of foreign invaders, leading to sequence-specific cleavage or degradation of the target DNA. Recent work has shown that the accidental or intentional targeting of the bacterial genome is cytotoxic and can lead to cell death. Here, we have demonstrated that genome targeting with CRISPR-Cas systems can be employed for the sequence-specific and titratable removal of individual bacterial strains and species. Using the type I-E CRISPR-Cas system in Escherichia coli as a model, we found that this effect could be elicited using native or imported systems and was similarly potent regardless of the genomic location, strand, or transcriptional activity of the target sequence. Furthermore, the specificity of targeting with CRISPR RNAs could readily distinguish between even highly similar strains in pure or mixed cultures. Finally, varying the collection of delivered CRISPR RNAs could quantitatively control the relative number of individual strains within a mixed culture. Critically, the observed selectivity and programmability of bacterial removal would be virtually impossible with traditional antibiotics, bacteriophages, selectable markers, or tailored growth conditions. Once delivery challenges are addressed, we envision that this approach could offer a novel means to quantitatively control the composition of environmental and industrial microbial consortia and may open new avenues for the development of “smart” antibiotics that circumvent multidrug resistance and differentiate between pathogenic and beneficial microorganisms. IMPORTANCE Controlling the composition of microbial populations is a critical aspect in medicine, biotechnology, and environmental cycles. While different antimicrobial strategies, such as antibiotics, antimicrobial peptides, and lytic bacteriophages, offer partial solutions, what remains elusive is a generalized and programmable strategy that can distinguish between even closely related microorganisms and that allows for fine control over the composition of a microbial population. This study demonstrates that RNA-directed immune systems in bacteria and archaea called CRISPR-Cas systems can provide such a strategy. These systems can be employed to selectively and quantitatively remove individual bacterial strains based purely on sequence information, creating opportunities in the treatment of multidrug-resistant infections, the control of industrial fermentations, and the study of microbial consortia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Silver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Self-citationPurification and Characterization
(2006) · Biomacromolecules · doi:10.1002/0470080124.ch3 · Cited by 2,309
Complete genome sequence of Salmonella enterica serovar Typhimurium LT2
McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J., Dante, M., Du, F., et al. (2001) · Nature · doi:10.1038/35101614 · Cited by 1,837
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
Mojica, F. J. M., Díez-Villaseñor, C., García-Martínez, J., & Almendros, C. (2009) · Microbiology · doi:10.1099/mic.0.023960-0 · Cited by 1,426
Comparative genomics of the lactic acid bacteria.
Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., Pavlov, A., Pavlova, N., Karamychev, V., Polouchine, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607117103 · Cited by 1,391
Self-citationBikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt520 · Cited by 1,145
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., & Siksnys, V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr606 · Cited by 834
Self-citationEnzymatic Assembly of Overlapping DNA Fragments
Gibson, D. G. (2011) · Methods in Enzymology · doi:10.1016/b978-0-12-385120-8.00015-2 · Cited by 736
Semenova, E., Jore, M. M., Datsenko, K. A., Semenova, A., Westra, E. R., Wanner, B., van der Oost, J., Brouns, S. J. J., & Severinov, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104144108 · Cited by 726
CRISPR-mediated adaptive immune systems in bacteria and archaea
Sorek, R., Lawrence, C. M., & Wiedenheft, B. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072911-172315 · Cited by 668
Self versus non-self discrimination during CRISPR RNA-directed immunity
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature · doi:10.1038/nature08703 · Cited by 637
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Cradick, T. J., Fine, E. J., Antico, C. J., & Bao, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt714 · Cited by 590
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565 · cited 1×
“Overall, CRISPR-Cas systems offer a unique opportunity for the selective and titratable removal of microorganisms for industrial and medical purposes, which can be added to the ever-expanding applications of this versatile immune system (11, 20, 23, 47, 48).”
BackgroundWiedenheft, B., van Duijn, E., Bultema, J. B., Waghmare, S. P., Zhou, K., Barendregt, A., Westphal, W., Heck, A. J. R., Boekema, E. J., Dickman, M. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102716108 · Cited by 449
Cas3 is a single‐stranded DNA nuclease and ATP‐dependent helicase in the CRISPR/Cas immune system
Sinkunas, T., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., & Siksnys, V. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.41 · Cited by 440
Self-citationUnderstanding Bacteriophage Specificity in Natural Microbial Communities
Koskella, B., & Meaden, S. (2013) · Viruses · doi:10.3390/v5030806 · Cited by 410
Self-targeting by CRISPR: gene regulation or autoimmunity?
Stern, A., Keren, L., Wurtzel, O., Amitai, G., & Sorek, R. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.008 · Cited by 384
Vercoe, R. B., Chang, J. T., Dy, R. L., Taylor, C., Gristwood, T., Clulow, J. S., Richter, C., Przybilski, R., Pitman, A. R., & Fineran, P. C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003454 · Cited by 341
Bikard, D., Hatoum-Aslan, A., Mucida, D., & Marraffini, L. A. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.003 · Cited by 318
The next generation of bacteriophage therapy
Lu, T. K., & Koeris, M. S. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.028 · Cited by 312
Parisien, A., Allain, B., Zhang, J., Mandeville, R., & Lan, C. Q. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03498.x · Cited by 300
Identification and characterization of E. coli CRISPR‐cas promoters and their silencing by H‐NS
Pul, Ü., Wurm, R., Arslan, Z., Geißen, R., Hofmann, N., & Wagner, R. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07073.x · Cited by 282
crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus
Karvelis, T., Gasiunas, G., Miksys, A., Barrangou, R., Horvath, P., & Siksnys, V. (2013) · RNA Biology · doi:10.4161/rna.24203 · Cited by 243
Self-citationIn vitro reconstitution of Cascade‐mediated CRISPR immunity in Streptococcus thermophilus
Sinkunas, T., Gasiunas, G., Waghmare, S. P., Dickman, M. J., Barrangou, R., Horvath, P., & Siksnys, V. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.352 · Cited by 228
Self-citationDealing with the Evolutionary Downside of CRISPR Immunity: Bacteria and Beneficial Plasmids
Jiang, W., Maniv, I., Arain, F., Wang, Y., Levin, B. R., & Marraffini, L. A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003844 · Cited by 228
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., & Norris, J. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1301-1307.2003 · Cited by 214
Studier, F. W., Daegelen, P., Lenski, R. E., Maslov, S., & Kim, J. F. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.021 · Cited by 200
RNA processing enables predictable programming of gene expression
Qi, L., Haurwitz, R. E., Shao, W., Doudna, J. A., & Arkin, A. P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2355 · Cited by 199
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Strong bias in the bacterial CRISPR elements that confer immunity to phage
Paez-Espino, D., Morovic, W., Sun, C. L., Thomas, B. C., Ueda, K.-I., Stahl, B., Barrangou, R., & Banfield, J. F. (2013) · Nature Communications · doi:10.1038/ncomms2440 · Cited by 180
Self-citationThe Escherichia coli CRISPR System Protects from λ Lysogenization, Lysogens, and Prophage Induction
Edgar, R., & Qimron, U. (2010) · Journal of Bacteriology · doi:10.1128/jb.00644-10 · Cited by 165
Russell, W. M., & Klaenhammer, T. R. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.9.4361-4364.2001 · Cited by 149
Yosef, I., Goren, M. G., Kiro, R., Edgar, R., & Qimron, U. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113519108 · Cited by 104
Entrapment of a bacterial plasmid in phospholipid vesicles: potential for gene transfer.
Fraley, R. T., Fornari, C. S., & Kaplan, S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3348 · Cited by 97
In vivo activity of CRISPR‐mediated virus defence in a hyperthermophilic archaeon
Manica, A., Zebec, Ž., Teichmann, D., & Schleper, C. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07586.x · Cited by 96
Oligonucleotide recombination in Gram-negative bacteria
Swingle, B. M., Markel, E. J., Costantino, N., Bubunenko, M. G., Cartinhour, S. W., & Court, D. L. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06976.x · Cited by 87
Electrotransformation of Lactobacillus acidophilus Group A1
Walker, D. C., Aoyama, K., & Klaenhammer, T. R. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08163.x · Cited by 87
Aklujkar, M., & Lovley, D. R. (2010) · BMC Evolutionary Biology · doi:10.1186/1471-2148-10-230 · Cited by 76
Lambrecht, J. A., Schmitz, G. E., & Downs, D. M. (2013) · mBio · doi:10.1128/mbio.00033-13 · Cited by 75
Wang, H. H., Xu, G., Vonner, A. J., & Church, G. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr183 · Cited by 75
Olsen, P. A., Randøl, M., Luna, L., Brown, T., & Krauss, S. J. K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.804 · Cited by 58
Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria
Westwater, C., Schofield, D. A., Schmidt, M. G., Norris, J. S., & Dolan, J. W. (2002) · Microbiology · doi:10.1099/00221287-148-4-943 · Cited by 34
Cited by
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459
Applications of CRISPR technologies in research and beyond
Barrangou, R., & Doudna, J. A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3659 · Cited by 1,005
Self-citationExploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
CRISPR-Cas immunity in prokaryotes
Marraffini, L. A. (2015) · Nature · doi:10.1038/nature15386 · Cited by 829
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808
Metadata
- Authors
- Gomaa, A. A., Klumpe, H. E., Luo, M. L., Selle, K., Barrangou, R., & Beisel, C. L.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2014-02-28
- Volume
- 5
- Issue
- 1
- Pages
- e00928-13
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2128112204
- Cited by
- 433
- References
- 58
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.